You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

RECTIV Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Rectiv, and when can generic versions of Rectiv launch?

Rectiv is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in RECTIV is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Rectiv

A generic version of RECTIV was approved as nitroglycerin by AM REGENT on May 24th, 1988.

  Try a Trial

Drug patent expirations by year for RECTIV
Drug Prices for RECTIV

See drug prices for RECTIV

Drug Sales Revenue Trends for RECTIV

See drug sales revenues for RECTIV

Recent Clinical Trials for RECTIV

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Forest LaboratoriesPhase 4

See all RECTIV clinical trials

Pharmacology for RECTIV
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation

US Patents and Regulatory Information for RECTIV

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie RECTIV nitroglycerin OINTMENT;INTRA-ANAL 021359-001 Jun 21, 2011 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.